• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Availability and use of rapid diagnostic tests for the management of acute childhood infections in Europe: A cross-sectional survey of paediatricians.

广告
作者单位: Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.;Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM). [1] Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom. [2] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Department of Infectious Diseases, Section of Paediatric Infectious Diseases, Imperial College London, London, United Kingdom.;Research in European Paediatric Emergency Medicine (REPEM). [3] ChildCare WorldWide, Padova, Italy.;European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet). [4] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Adelson School of Medicine, Ariel University, Ariel, Israel.;Pediatric Clinic, Maccabi Healthcare Services, Tel Aviv, Israel. [5] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Paediatric Department, Larnaca General Hospital, Larnaca, Cyprus.;Medical School, European University Cyprus, Nicosia, Cyprus. [6] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Primary Care Paediatrician, Health Care Centre Pere Grau, Barcelona, Spain. [7] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Great North Children's Hospital, Paediatric Immunology, Infectious Diseases & Allergy, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.;Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom. [8] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Great North Children's Hospital, Paediatric Immunology, Infectious Diseases & Allergy, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.;Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom. [9] Centre d'Investigation Clinique CIC1413, INSERM-Nantes University Hospital, Nantes, France. [10] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Medical University of Graz, Graz, Austria. [11] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Medical University of Graz, Graz, Austria. [12] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;BioMérieux, Lyon, France. [13] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;University Hospital, Ludwig Maximilians University (LMU), Munich, Germany. [14] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;P. and A. Kyriakou Children's Hospital, Athens, Greece. [15] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Children Clinical University Hospital, Riga, Latvia. [16] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Radboud University Medical Center, Nijmegen, the Netherlands. [17] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands. [18] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Research in European Paediatric Emergency Medicine (REPEM).;Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands. [19] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands. [20] Research in European Paediatric Emergency Medicine (REPEM).;Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands. [21] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Amsterdam University Medical Center, Amsterdam, the Netherlands. [22] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia. [23] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain. [24] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Bern University Hospital, University of Bern, Bern, Switzerland. [25] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Alder Hey Children's Hospital, Liverpool, United Kingdom. [26] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Department of Paediatrics, Oxford Vaccine Group, University of Oxford, Oxford, United Kingdom. [27] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Department of Infectious Diseases, Section of Paediatric Infectious Diseases, Imperial College London, London, United Kingdom. [28] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;University of Zagreb, School of Medicine, Andrija Štampar School of Public Health, Zagreb, Croatia. [29] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Primary Care Paediatrician, BVKJ, Hagen, Germany. [30] Research in European Paediatric Emergency Medicine (REPEM).;Department of Woman's and Child's Health Padova University Hospital, Padua, Italy. [31] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Vilnius University Medical Faculty, Institute of Clinical Medicine, Clinic of Children's Diseases, Vilnius, Lithuania. [32] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Department of Paediatrics, Helsinki University Hospital, Helsinki, Finland. [33] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Attiko University Hospital, Chaidari, Greece. [34] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Association of Hungarian Primary Care Paediatricians, Budapest, Hungary. [35] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Department of Paediatrics and Adolescent Health at Mater Dei Hospital, Valletta, Malta. [36] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Paediatric Research Institute, University of Oslo, Oslo, Norway. [37] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Dutch Society of Paediatrics NVK, Utrecht, the Netherlands. [38] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Medical College of Rzeszow University, Rzeszów, Poland. [39] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Zdravstveni dom Domžale, Slovenian Paediatric Society, Burnaby, Slovenia. [40] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Hospital Beatriz Ângelo, Loures, Portugal. [41] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Kinderärzte KurWerk, Burgdorf, Switzerland. [42] European Academy of Paediatrics Research in Ambulatory Settings network (EAPRASnet).;Ukrainian Academy of Pediatric Specialties, Ukraine. [43] Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Service de Pédiatrie-Urgences, AP-HP, Hôpital Louis-Mourier, Colombes, France. [44] Hospital Universitario Virgen de la Arrixaca, Murcia, Spain. [45] Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.;Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management Across the European Union (PERFORM).;Department of Paediatrics, St Mary's Imperial College Hospital, London, United Kingdom. [46]
DOI 10.1371/journal.pone.0275336
PMID 36538525
发布时间 2024-09-09
提交
  • 浏览0
PloS one

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷